Novo Nordisk A/S ( NONOF) - Stock Earnings
NONOF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
NONOF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 4.2 billion USD | 12.4 billion USD |
| 2026Q1 | 7.4 billion USD | 14.9 billion USD |
| 2026Q2 | 3.2 billion USD | 12.0 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
NONOF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 12.4 billion USD | 34.4 billion USD |
| 2024 | 14.1 billion USD | 40.5 billion USD |
| 2025 | 16.1 billion USD | 48.5 billion USD |
| 2026 Est. | — | — |
NONOF
Price: $38.15
Dividend Yield: 4.85%
Forward Dividend Yield: 3.04%
Payout Ratio: 34.62%
Dividend Per Share: 1.16 USD
Earnings Per Share: 4.05 USD
P/E Ratio: 11.58
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: Denmark
Market Capitalization: 164.8 billion
Average Dividend Frequency: 2
Years Paying Dividends: 18
DGR3: 30.00%
DGR5: 24.25%
DGR10: 21.21%